Publications by authors named "Steven Edelman"

Claim this Profile
I
Improved glycemic outcomes in people with type 2 diabetes using smart blood glucose monitoring integrated with popular digital health therapeutics.
Mike Grady, Elizabeth Holt, Hilary Cameron, Steven Edelman

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Continuous Glucose Monitoring Sourcing on Real-World Adherence and Health Care Costs: A Comparative Analysis by Insurance Type.
Jason C Allaire, Consuela Dennis, Eugene E Wright, Steven V Edelman, Arti Masturzo

Clin Diabetes· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.
Nicole L Spartano, Brenton Prescott, Maura E Walker, Eleanor Shi, Guhan Venkatesan, Steven V Edelman

J Diabetes Sci Technol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review.
Diana Brixner, Steven V Edelman, Ray Sieradzan, James R Gavin

Diabetes Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.
Rita R Kalyani, Myriam Z Allende-Vigo, Kellie J Antinori-Lent, Kelly L Close, Sandeep R Das, Steven V Edelman

J Clin Endocrinol Metab· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Steven V Edelman

J Diabetes Sci Technol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges.
Preethika Ekanayake, Steven Edelman

Diabetes Obes Metab· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Intervention by Family Physicians to Delay Type 1 Diabetes.
Steven Edelman

J Fam Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100).
Steven Edelman, Jennifer Goldman, Daniel C Malone, Ronald Preblick, Kovida Munaga

Clin Diabetes· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin.
Jennifer D Goldman, Eugenio Angueira-Serrano, Jeffrey S Gonzalez, Christianne Pang, Jacqueline Tait, Steven Edelman

Clin Diabetes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence and adherence in people with type 2 diabetes switching to iGlarLixi vs free-dose combinations of basal insulin and glucagon-like peptide 1 receptor agonist.
Steven Edelman, Doreen Cassarino, David Kayne, Terry Dex, Xuan Li

J Manag Care Spec Pharm· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes.
David Kerr, Steven Edelman, Giacomo Vespasiani, Kamlesh Khunti

Endocr Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing continuous glucose monitoring in primary care practice: What the numbers mean.
Steven V Edelman, Tricia Santos Cavaiola, Schafer Boeder, Jeremy Pettus

Prim Care Diabetes· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic characteristics and acute complications among adults with type 1 diabetes: Comparison of two multicentre databases from Germany and the United States.
Alexander J Eckert, Fang L Zhou, Julia M Grimsmann, Jeremy H Pettus, Wolfgang Kerner, Steven V Edelman

J Diabetes Complications· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m.
Thomas Danne, Steven Edelman, Juan Pablo Frias, Francisco Javier Ampudia-Blasco, Philip Banks

Diabetes Obes Metab· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Second-Generation Basal Insulin Analogs: A Review of the Evidence from Continuous Glucose Monitoring.
Tadej Battelino, Steven V Edelman, Rimei Nishimura, Richard M Bergenstal

Diabetes Technol Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management Goals.
Hope Warshaw, Steven V Edelman

Clin Diabetes· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.
Per-Henrik Groop, Paresh Dandona, Moshe Phillip, Pieter Gillard, Steven Edelman

Lancet Diabetes Endocrinol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey.
Steven V Edelman, Richard Wood, Michelle Roberts, Jay H Shubrook

Clin Diabetes· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database.
Jeremy H Pettus, Fang Liz Zhou, Leah Shepherd, Katie Mercaldi, Ronald Preblick, Steven V Edelman

Diabetes Obes Metab· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tribute to Robert Roy Henry-The Classic "Academic Triple Threat": Accomplished Researcher, Inspiring Teacher, and Compassionate Clinician.
Steven Edelman, Jerrold Olefsky, Sunder Mudaliar, Ted Ciaraldi, Alain Baron

Diabetes Care· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
Jeremy H Pettus, Fang Liz Zhou, Leah Shepherd, Ronald Preblick, Phillip R Hunt, Steven V Edelman

Diabetes Care· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
Steven V Edelman, Anastasia Ermakova, Yan Xiong, Ray Sieradzan, Stephanie D Taylor

J Manag Care Spec Pharm· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients.
Ian Blumer, Lucia M Novak, Steven Edelman, Tricia Santos Cavaiola

Clin Diabetes· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures.
Jeremy H Pettus, Jake A Kushner, Virginia Valentine, Richard Wood, Christianne Pang, Steven E Edelman

Diabetes Technol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis